NCT00004997View on ClinicalTrials.gov

Leucovorin for the Treatment of 5 q Minus Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

April 30, 1998

Study Completion Date

July 31, 2002

Conditions
5q Minus SyndromeMyelodysplastic Syndrome
Interventions
DRUG

Leucovorin

Trial Locations (1)

20892

Warren G. Magnuson Clinical Center (CC), Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00004997 - Leucovorin for the Treatment of 5 q Minus Syndrome | Biotech Hunter | Biotech Hunter